Phase 3
Completed N=66
Laser Acupuncture for Postpartum Weight Retention
Postpartum Weight Retention
Source: ClinicalTrials.gov NCT02840916 ↗
Enrolled (actual)
66
Serious AEs
0.0%
Results posted
Jan 2017
Primary outcomePrimary: Body Mass Index (BMI) — 33.62; 28.03; 26.90; 26.99 kg/m^2
◆ Published Evidence
Established
37citations · ~2 / year
Clinical observations on laser acupuncture in simple obesity therapy.
Summary
Objective: To determine the therapeutic effect of acupuncture on postpartum weight retention.
Methods: 66 subjects after delivery with postpartum weight retention will be randomly divided into laser acupuncture and control group. A single-blind clinical trial will be conducted and the subjects will be treated with verum or sham laser acupuncture 5 sessions per week. After about 3 weeks of treatment, the differences of the subjects' body weight, body mass index, and waist circumference will be analyzed with ANOVA between laser acupuncture and control group.
Linked Publications
-
Clinical observations on laser acupuncture in simple obesity therapy.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Body Mass Index (BMI) |
33.62; 28.03; 26.90; 26.99; 26.16; 26.64 | — |
| SECONDARY Waist-to-buttock Ratio (WBR) |
0.93; 0.92; 0.92; 0.90 | — |
| SECONDARY Body Fat Percentage (BFP) |
36.94; 36.02; 35.75; 35.37 | — |
Eligibility Criteria
Inclusion Criteria
- postpartum duration of 25;
- age > 20 years;
- did not use any other medications for weight loss during the study period; and
- provided informed consent.
Exclusion Criteria
- presence of a pacemaker;
- history of seizure or epilepsy;
- taking immunosuppressant medication;
- cancer;
- infectious disease of the skin;
- taking medications for weight loss, including Chinese herbal preparations, during the study period;
- receiving other treatment, including supplements, herbs, and medications for weight gain prior to entering the study;
- comorbidities (hypothyroidism, renal disease, etc.) that the physician believes would affect the findings;
- unable to undergo LAT due to other medical conditions; and
- lack of informed consent.
Data sourced from ClinicalTrials.gov (NCT02840916) and the linked publication. Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.